Russ Cerny Joins ProCare Rx

The ProCare Rx Team • April 8, 2024
Russ Cerny

Gainesville, GA – ProCare Rx is excited to announce that Mr. Russell Cerny has joined the company effective March 25, 2024. In his role as Senior Vice President, Mr. Cerny will be responsible for expanding our strategic partnerships with Health Plans, Health Systems, Benefit Consultants, and large Employer groups.


Doyle Jensen, Chief Growth Officer said, "Russ has great integrity and a deep understanding of the industry that will help us deliver our direct-source message of customized and cost effective pharmacy benefit solutions that address the needs of our future customers".


As a business development professional with over two decades in the industry, Russ understands problem solving from both an operational and account management perspective. This extensive and varied background in providing pharmacy related services enables Russ to focus on cost containment, membership satisfaction, and ultimately, patient well-being for his clients.


Mr. Cerny said, “I'm proud to have joined ProCare Rx, an organization committed to routine technological development and enhancement of their own proprietary claims processing system. Our team provides clients with as little or as much control as desired when it comes to administering pharmacy benefits. We'll support a model that meets our clients’ needs and every client is unique and needs a solution built specifically for them.”


About ProCare Rx

ProCare Rx is a privately held, direct-source pharmacy benefit administrator delivering industry leading cost savings and superior service to health plans, health systems, unions, and many other payer organizations nationwide. If you are interested in learning more about how ProCare Rx can reduce your pharmacy spend and improve your health outcomes, please contact: sales@procarerx.com.


About ProCare Rx
ProCare Rx is a privately held, independent pharmacy benefit manager (PBM) that has empowered healthcare and self-insured organizations since 1988. We provide fully integrated, in-house solutions—including claims adjudication, clinical program design, pharmacy network access, cost containment, and data analytics—all supported in the U.S. Our flexible, transparent model serves self-insured employers, third-party administrators (TPA), brokers, health plans, health systems, managed care organizations (MCO), unions, workers’ compensation programs, Medicare, Medicaid, hospices, and other PBMs. With a proprietary technology platform, commitment to ethical operations, and a focus on lowest net cost, ProCare Rx delivers long-term value, clinical performance, and trusted pharmacy benefit partnerships.

Media Contact:
Marc Cohen, VP, Marketing and Sales
marketing@ProCareRx.com

By ProCare Rx Team July 8, 2025
Prescription Drug Pricing: Will Policy Fix What Patients Feel?
By ProCare Rx Team June 2, 2025
Is Your PBM Working for You…Or Against You? How to Ask the Right Questions and Spot Red Flags in Pharmacy Benefit Management
By ProCare Rx May 20, 2025
ProCare Rx Announces New Executive Appointment and Launch of Technology Division to Drive Innovation and Growth The newly created role is expected to solidify leadership of the core technology infrastructure to both enhance support for current clients as well as developing additional value-added offerings to the marketplace.
By ProCare Rx Team May 19, 2025
Understanding the “Most Favored Nation” Drug Pricing Rule
By ProCare Rx Team May 19, 2025
ProCare Rx's Innovative Approach to Pharmacy Benefit Management
By ProCare Rx May 6, 2025
ProCare Rx Appoints John Drakulich as President of their PBM Business
By ProCare Rx Team April 21, 2025
ProCare Rx’s ProCare PharmacyCare, LLC Earns URAC Accreditation in Specialty Pharmacy
By ProCare Rx Team April 15, 2025
Prescription Drug Reform Gains Momentum: What the New Senate Bill Means for Plan Sponsors
By ProCare Rx Team April 2, 2025
The White House recently launched the Make America Healthy Again Commission to address some of the biggest challenges in U.S. healthcare—including chronic disease, medication reliance, and drug safety. While the full impact remains to be seen, this initiative signals potential shifts in how prescription drugs are evaluated, priced, and prescribed. For plan sponsors, employers, and pharmacy benefits managers (PBMs), the key question is: How can we ensure medication access, affordability, and safety while staying ahead of possible regulatory changes? Reevaluating Medication Reliance One of the Commission’s focus areas is over-reliance on medication and treatments. This could lead to a push for more careful prescribing practices, increased scrutiny of high-cost drugs, and expanded support for alternative treatment methods. PBMs can play a proactive role by ensuring plan designs promote clinically effective, cost-conscious prescribing, including: Encouraging use of generics and biosimilars when available Implementing clinical programs that support appropriate prescribing Providing medication management resources to help members navigate treatment options Increased Attention on Drug Safety & Pricing The Commission also highlights food and drug quality and safety , reinforcing the need for greater transparency in pharmaceutical manufacturing and pricing . This could mean: Tighter regulations on imported medications and supply chain oversight More scrutiny on rebate structures and how drug prices are set A renewed focus on affordability strategies for plan sponsors and consumers For PBMs and health plans, transparent pricing models and clear rebate structures will be key to staying compliant and ensuring members have access to safe, fairly priced medications. Eliminating Conflicts of Interest in Health Research Another priority for the Commission is ensuring federally funded health research is free from conflicts of interest . This could impact how drug effectiveness is studied, how formularies are built, and how treatment guidelines are developed. Employers and health plans should work with PBMs that prioritize: Data-driven formulary management based on independent clinical outcomes Objective drug evaluations to balance cost and effectiveness Transparent partnerships with health providers and pharmaceutical companies What’s Next? The Make America Healthy Again Commission is still in its early stages, but its focus on medication reliance, drug safety, and pharmaceutical pricing should not be ignored. Employers and plan sponsors should be prepared for potential policy changes that could impact pharmacy benefits. By working with PBMs that prioritize clinical integrity, cost control, and member education , organizations can stay ahead of the curve and continue to provide high- quality, affordable healthcare solutions. Would you like to review your pharmacy benefits strategy? Let’s talk. Click the button below to learn more about ProCare Rx's Offering and signup to hear from one of our sales team.
By ProCare Rx Team March 3, 2025
FTC Report Reveals $7.3 Billion in Excessive PBM Revenues—What It Means for Employers and Patients
More Posts